AI and neuroscience entrepreneur Katharina Volz

When it comes to curing Parkinson’s disease, the biggest obstacle is in making use of siloed research. So says Katharina Volz, founder and CEO of OccamzRazor, an AI-neuroscience startup. They’ve built a “super brain” to read everything ever published about Parkinson’s and related diseases, and to make connections to clinical research no human possibly could. Hear Volz’s plans for finding cures for patient subgroups — and why she recommends wearing rollerblades in the lab.